Novel-drugs United States

BioNumerik is a leader in a powerful new area called "mechanism-based" drug discovery, which employs multi-disciplinary science, including chemistry, biology and quantum physics, integrated with high performance computational technologies, to identify ...

BioNumerik is a leader in a powerful new area called "mechanism-based" drug discovery, which employs multi-disciplinary science, including chemistry, biology and quantum physics, integrated with high performance computational technologies, to identify ...

About Eyetech Pharmaceuticals, Inc. Eyetech Pharmaceuticals, Inc. is a biopharmaceutical company that specializes in the development and commercialization of novel therapeutics to treat diseases of the eye. Eyetech's initial focus is on diseases affecting ...

BioNumerik is a leader in a powerful new area called "mechanism-based" drug discovery, which employs multi-disciplinary science, including chemistry, biology and quantum physics, integrated with high performance computational technologies, to identify ...

Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer. The Company's lead compound ...

It is Q-RNA's mission to develop its novel drug target and discovery systems and use them to discover and optimize therapeutics to treat Alzheimer's disease (AD), a disorder with a large unmet medical need. With its initial focus on Alzheimer's disease ...

Argolyn Bioscience, Inc. is a privately held biopharmaceutical company dedicated to discovering and developing novel peptide drug candidates to treat psychosis, pain, and other serious diseases and disorders. Our most advanced development candidate is ...

PCI Biotech AS is a Norwegian company located in Oslo that develops and commercialises a novel drug delivery technology, photochemical internalisation (PCI). The company was established in 2000 as a subsidiary of the Norwegian pharmaceutical company Photocure ...

PCI Biotech AS is a Norwegian company located in Oslo that develops and commercialises a novel drug delivery technology, photochemical internalisation (PCI). The company was established in 2000 as a subsidiary of the Norwegian pharmaceutical company Photocure ...

Argolyn Bioscience, Inc. is a privately held biopharmaceutical company dedicated to discovering and developing novel peptide drug candidates to treat psychosis, pain, and other serious diseases and disorders. Our most advanced development candidate is ...

Antares Pharma, Inc. (Antares) is a specialized pharma product development and pipeline company with drug delivery platforms, including Advanced Transdermal Delivery (ATD) gels, oral (Easy Tec) tablets, disposable pressure assisted auto injection systems ...

PolyMedix, Inc. is a biotechnology company focused on treating infectious diseases and acute cardiovascular disorders with synthetic small molecule compounds that mimic the activity of natural protein molecules, compounds referred to as biomimetics. Using ...

Eurand N.V. is a specialty pharmaceutical company that develops, manufactures and commercializes pharmaceutical and biopharmaceutical products based on its drug formulation technologies. The Company has applied its technologies to drug products in a range ...

Antigenics Inc. is a biotechnology company focused on developing technologies and product candidates to treat cancers and infectious diseases, primarily based on immunological approaches. The Company’s principal product candidate is Oncophage (vitespen) ...

Sonus Pharmaceuticals, Inc. (Sonus) is focused on the development of cancer drugs. The Company has one drug in clinical development and two earlier stage programs. SN2310 Injectable Emulsion is being developed as a cancer therapy. As of December 31, 2007 ...

EiRx Therapeutics Plc is principally engaged in the discovery and development of novel therapeutics for the treatment of cancer. The Company conducts drug discovery from its laboratories in Cork and in Aberdeen, Scotland, and has an initial focus on treatment ...

Intra-Cellular Therapies (ITI) is developing novel drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the Central Nervous System (CNS).

Sonus Pharmaceuticals, Inc. (Sonus) is focused on the development of cancer drugs. The Company has one drug in clinical development and two earlier stage programs. SN2310 Injectable Emulsion is being developed as a cancer therapy. As of December 31, 2007 ...

Cadus Corporation is engaged in the development and application of yeast-based and other drug discovery technologies. The Company has a wholly owned subsidiary, Cadus Technologies, Inc. (the Subsidiary), which holds all applications, licenses and drug ...

PolyMedix, Inc. is a biotechnology company focused on treating infectious diseases and acute cardiovascular disorders with synthetic small molecule compounds that mimic the activity of natural protein molecules, compounds referred to as biomimetics. Using ...

About Eyetech Pharmaceuticals, Inc. Eyetech Pharmaceuticals, Inc. is a biopharmaceutical company that specializes in the development and commercialization of novel therapeutics to treat diseases of the eye. Eyetech's initial focus is on diseases affecting ...

Intra-Cellular Therapies (ITI) is developing novel drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the Central Nervous System (CNS). We combine the efforts of medicinal chemists, pharmacologists, biologists and ...